Literature DB >> 2448513

Analysis of estrogen receptors in human breast cancer by assays using monoclonal antibodies and by the dextran-coated charcoal method.

N Fujino1, K Sakamoto, N Shigaki, J Yamashita, M Kimura, M Akagi.   

Abstract

Estrogen receptors (ER) were analyzed in 63 human breast cancers by immunocytochemical assay, and by enzyme-immunoassay, using monoclonal antibodies against human ER protein, and also by the dextran-coated charcoal method. The specific staining was observed only in the nucleus of cancer cells by the immunocytochemical assay, and the presence of nuclear staining by this assay was closely associated with the estimation of the cytosolic ER content by both the dextran-coated charcoal method and the enzyme-immunoassay. In the latter, the cytosolic ER content correspondingly increased with the nuclear ER content. Both the cytosolic and nuclear ER contents correlated well with those obtained by the dextran-coated charcoal method. Furthermore, the cytosolic ER contents obtained by the enzyme-immunoassay and the dextran-coated charcoal method correlated significantly with the age of the patient, but not with the nuclear ER contents. These above mentioned results suggest that ER is present mainly in the nucleus of breast cancer cells and that the cytosolic ER obtained by these two assays is the unoccupied one released from the nucleus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2448513     DOI: 10.1007/bf02470636

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  34 in total

1.  Thyroid hormone receptors. Binding characteristics and lack of hormonal dependency for nuclear localization.

Authors:  B J Spindler; K M MacLeod; J Ring; J D Baxter
Journal:  J Biol Chem       Date:  1975-06-10       Impact factor: 5.157

2.  Estrogen receptors in the rat uterus. Multiple forms produced by concentration-dependent aggregation.

Authors:  G M Stancel; K M Leung; J Gorski
Journal:  Biochemistry       Date:  1973-05-22       Impact factor: 3.162

Review 3.  Receptors reconsidered: a 20-year perspective.

Authors:  E V Jensen; G L Greene; L E Closs; E R DeSombre; M Nadji
Journal:  Recent Prog Horm Res       Date:  1982

4.  Monoclonal antibodies against a component related to soluble estrogen receptor.

Authors:  A I Coffer; K M Lewis; A J Brockas; R J King
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

5.  Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor.

Authors:  A I Coffer; G H Spiller; K M Lewis; R J King
Journal:  Cancer Res       Date:  1985-08       Impact factor: 12.701

6.  The value of estrogen and progesterone receptors in the treatment of breast cancer.

Authors:  C K Osborne; M G Yochmowitz; W A Knight; W L McGuire
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

7.  Monoclonal antibodies to human estrogen receptor.

Authors:  G L Greene; C Nolan; J P Engler; E V Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

8.  Studies on estrogen receptors and regression in human breast cancer.

Authors:  J K MacFarlane; D Fleiszer; A G Fazekas
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

9.  Histochemical studies with a monoclonal antibody raised against a partially purified soluble estradiol receptor preparation from human myometrium.

Authors:  R J King; A I Coffer; J Gilbert; K Lewis; R Nash; R Millis; S Raju; R W Taylor
Journal:  Cancer Res       Date:  1985-11       Impact factor: 12.701

10.  Comparison of immunocytochemical and steroid-binding assays for estrogen receptor in human breast tumors.

Authors:  W J King; E R DeSombre; E V Jensen; G L Greene
Journal:  Cancer Res       Date:  1985-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.